1. Home
  2. SGMA vs RNAZ Comparison

SGMA vs RNAZ Comparison

Compare SGMA & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMA
  • RNAZ
  • Stock Information
  • Founded
  • SGMA 1993
  • RNAZ 2016
  • Country
  • SGMA United States
  • RNAZ United States
  • Employees
  • SGMA N/A
  • RNAZ N/A
  • Industry
  • SGMA Electrical Products
  • RNAZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGMA Technology
  • RNAZ Health Care
  • Exchange
  • SGMA Nasdaq
  • RNAZ Nasdaq
  • Market Cap
  • SGMA 6.2M
  • RNAZ 6.1M
  • IPO Year
  • SGMA 1994
  • RNAZ 2021
  • Fundamental
  • Price
  • SGMA $2.97
  • RNAZ $7.97
  • Analyst Decision
  • SGMA
  • RNAZ Strong Buy
  • Analyst Count
  • SGMA 0
  • RNAZ 1
  • Target Price
  • SGMA N/A
  • RNAZ $280.00
  • AVG Volume (30 Days)
  • SGMA 64.8K
  • RNAZ 32.8K
  • Earning Date
  • SGMA 03-14-2025
  • RNAZ 08-13-2025
  • Dividend Yield
  • SGMA N/A
  • RNAZ N/A
  • EPS Growth
  • SGMA N/A
  • RNAZ N/A
  • EPS
  • SGMA N/A
  • RNAZ N/A
  • Revenue
  • SGMA $311,706,094.00
  • RNAZ N/A
  • Revenue This Year
  • SGMA N/A
  • RNAZ N/A
  • Revenue Next Year
  • SGMA N/A
  • RNAZ N/A
  • P/E Ratio
  • SGMA N/A
  • RNAZ N/A
  • Revenue Growth
  • SGMA N/A
  • RNAZ N/A
  • 52 Week Low
  • SGMA $0.96
  • RNAZ $6.15
  • 52 Week High
  • SGMA $6.47
  • RNAZ $970.20
  • Technical
  • Relative Strength Index (RSI)
  • SGMA 73.16
  • RNAZ 47.04
  • Support Level
  • SGMA $2.92
  • RNAZ $7.32
  • Resistance Level
  • SGMA $3.00
  • RNAZ $8.48
  • Average True Range (ATR)
  • SGMA 0.02
  • RNAZ 0.58
  • MACD
  • SGMA -0.06
  • RNAZ 0.41
  • Stochastic Oscillator
  • SGMA 68.75
  • RNAZ 70.77

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: